Heterodimeric Bispecific Antibodies

Patent No. EP2970484 (titled "Heterodimeric Bispecific Antibodies") was filed by Amgen on Mar 13, 2014. The application was issued on Sep 21, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
RICKERFeb 15, 2019WALLINGER RICKER SCHLOTTER TOSTMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2970484

AMGEN
Application Number
EP14722862A
Filing Date
Mar 13, 2014
Status
Patent Maintained As Amended
Aug 19, 2022
Publication Date
Sep 21, 2022